New therapeutic indications for Cys‐LT1 antagonists: atopic dermatitis and urticaria

[1]  R. Asero.  Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[2]  Y. Berkun,et al.  Successful treatment of delayed pressure urticaria with montelukast , 2000, Allergy.

[3]  Lynn Wei,et al.  Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma , 1999, Annals of Internal Medicine.

[4]  M. Ellis,et al.  Successful treatment of chronic urticaria with leukotriene antagonists. , 1998, The Journal of allergy and clinical immunology.

[5]  J. Carucci,et al.  The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. , 1998, Archives of dermatology.

[6]  Bennett,et al.  Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging , 1998, The British journal of dermatology.

[7]  M. Church,et al.  Measurement of nitric oxide concentration in human skin in vivo using dermal microdialysis , 1998, Experimental physiology.

[8]  S. Spector,et al.  Antileukotrienes in chronic urticaria. , 1998, The Journal of allergy and clinical immunology.

[9]  Horio,et al.  Aspirin‐sensitive urticaria: provocation with a leukotriene receptor antagonist , 1998, The British journal of dermatology.

[10]  C. Dollery,et al.  Urinary leukotriene E4 levels in patients with atopic dermatitis , 1997, The British journal of dermatology.

[11]  C. Bruijnzeel-Koomen,et al.  Evaluation of the atopy patch test and the cutaneous late-phase reaction as relevant models for the study of allergic inflammation in patients with atopic eczema. , 1996, The Journal of allergy and clinical immunology.

[12]  J Berth-Jones,et al.  Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis * , 1996, The British journal of dermatology.

[13]  J. Frölich,et al.  Enhanced synthesis of cysteinyl leukotrienes in atopic dermatitis , 1993, The British journal of dermatology.

[14]  C. Bruijnzeel-Koomen,et al.  Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. , 1992, The Journal of allergy and clinical immunology.

[15]  S. Shuster,et al.  Cyclosporin A in atopic dermatitis: therapeutic resonse is disociated form effects on allergic reactons , 1991, The British journal of dermatology.

[16]  A. Kagey‐Sobotka,et al.  The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR). , 1989, The Journal of allergy and clinical immunology.

[17]  K. Kragballe,et al.  Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations. , 1989, The Journal of allergy and clinical immunology.

[18]  P. Ind,et al.  Leukotriene E4 release in cold urticaria , 1989, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  B. Zweiman,et al.  Accumulation of leukotriene C4 and histamine in human allergic skin reactions. , 1985, The Journal of clinical investigation.

[20]  K. Frank Austen,et al.  Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin , 1983 .